Francesco Ramundo

553 total citations
12 papers, 345 citations indexed

About

Francesco Ramundo is a scholar working on Genetics, Rheumatology and Oncology. According to data from OpenAlex, Francesco Ramundo has authored 12 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Rheumatology and 4 papers in Oncology. Recurrent topics in Francesco Ramundo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and COVID-19 Clinical Research Studies (2 papers). Francesco Ramundo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and COVID-19 Clinical Research Studies (2 papers). Francesco Ramundo collaborates with scholars based in Italy, United States and Japan. Francesco Ramundo's co-authors include Silvia Bellesi, Gina Zini, Giuseppe d’Onofrio, Valerio De Stefano, Alessandro M. Vannucchi, Elena Rossi, Paola Guglielmelli, Giuseppe Gaetano Loscocco, Ayalew Tefferi and Patrizia Chiusolo and has published in prestigious journals such as Blood, British Journal of Haematology and Haematologica.

In The Last Decade

Francesco Ramundo

11 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Ramundo Italy 6 144 137 104 85 71 12 345
Franklin Fuda United States 11 89 0.6× 57 0.4× 145 1.4× 75 0.9× 16 0.2× 51 395
Ilya Kirgner Israel 10 44 0.3× 86 0.6× 119 1.1× 53 0.6× 31 0.4× 31 285
Ambra Paolini Italy 9 46 0.3× 42 0.3× 77 0.7× 44 0.5× 19 0.3× 16 199
Yuichiro Nawa Japan 10 68 0.5× 54 0.4× 145 1.4× 26 0.3× 13 0.2× 32 337
S. T. S. Durrant United Kingdom 13 38 0.3× 67 0.5× 152 1.5× 66 0.8× 39 0.5× 25 381
Sharat Damodar India 8 90 0.6× 38 0.3× 130 1.3× 32 0.4× 7 0.1× 29 283
Nashla Barroso United States 4 34 0.2× 26 0.2× 48 0.5× 58 0.7× 107 1.5× 7 324
Daniel Mrak Austria 8 162 1.1× 54 0.4× 16 0.2× 13 0.2× 80 1.1× 16 284
Vincenzo Nasillo Italy 10 79 0.5× 34 0.2× 66 0.6× 36 0.4× 6 0.1× 12 216
Seçkin Çağırgan Türkiye 9 26 0.2× 58 0.4× 187 1.8× 56 0.7× 29 0.4× 45 329

Countries citing papers authored by Francesco Ramundo

Since Specialization
Citations

This map shows the geographic impact of Francesco Ramundo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Ramundo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Ramundo more than expected).

Fields of papers citing papers by Francesco Ramundo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Ramundo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Ramundo. The network helps show where Francesco Ramundo may publish in the future.

Co-authorship network of co-authors of Francesco Ramundo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Ramundo. A scholar is included among the top collaborators of Francesco Ramundo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Ramundo. Francesco Ramundo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ramundo, Francesco, Elena Rossi, Ketty Peris, et al.. (2025). Improving the management of Polycythemia Vera patients eligible for cytoreduction: report of a multidisciplinary advisory board. Current Medical Research and Opinion. 41(2). 239–245.
2.
Zini, Gina, Patrizia Chiusolo, Esther Diana Rossi, et al.. (2024). Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates. International Journal of Laboratory Hematology. 46(3). 474–480. 3 indexed citations
3.
Barbui, Tiziano, Alessandra Carobbio, Paola Guglielmelli, et al.. (2024). Neutrophil/lymphocyte ratio identifies low‐risk polycythaemia vera patients for early Ropeginterferon alfa‐2b therapy. British Journal of Haematology. 205(6). 2287–2294. 5 indexed citations
4.
Ramundo, Francesco, Mônica Lanzoni Rossi, Roberto Maggi, et al.. (2024). Familial Predisposition in Myeloproliferative Neoplasms: An NGS-Driven Analysis. Blood. 144(Supplement 1). 1763–1763. 1 indexed citations
5.
Carobbio, Alessandra, Alessandro M. Vannucchi, Valerio De Stefano, et al.. (2022). Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera. Blood Cancer Journal. 12(2). 28–28. 51 indexed citations
6.
Loscocco, Giuseppe Gaetano, Paola Guglielmelli, Naseema Gangat, et al.. (2021). Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American Journal of Hematology. 96(11). 1472–1480. 26 indexed citations
7.
Guglielmelli, Paola, Giuseppe Gaetano Loscocco, Carmela Mannarelli, et al.. (2021). JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood Cancer Journal. 11(12). 199–199. 63 indexed citations
8.
Gresele, Paolo, Stefania Momi, Rossella Marcucci, et al.. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. Haematologica. 106(12). 3034–3045. 27 indexed citations
9.
Carobbio, Alessandra, Alessandro M. Vannucchi, Paola Guglielmelli, et al.. (2021). Neutrophil-to-Lymphocyte Ratio (NLR) Is a Risk Factor for Venous Thrombosis in Polycythemia Vera. Blood. 138(Supplement 1). 1499–1499. 1 indexed citations
10.
Loscocco, Giuseppe Gaetano, Paola Guglielmelli, Carmela Mannarelli, et al.. (2021). A JAK2V617F Variant Allele Frequency Greater Than 50% Identifies Patients with Polycythemia Vera at High Risk for Venous Thrombosis. Blood. 138(Supplement 1). 237–237. 3 indexed citations
11.
Zini, Gina, Silvia Bellesi, Francesco Ramundo, & Giuseppe d’Onofrio. (2020). Morphological anomalies of circulating blood cells in COVID‐19. American Journal of Hematology. 95(7). 870–872. 89 indexed citations
12.
Bellesi, Silvia, Elisabetta Metafuni, Stefan Hohaus, et al.. (2020). Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients. British Journal of Haematology. 191(2). 207–211. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franklin Fuda Breakdown of academic impact, for papers by Ilya Kirgner Breakdown of academic impact, for papers by Ambra Paolini Breakdown of academic impact, for papers by Yuichiro Nawa Breakdown of academic impact, for papers by S. T. S. Durrant Breakdown of academic impact, for papers by Sharat Damodar Breakdown of academic impact, for papers by Nashla Barroso Breakdown of academic impact, for papers by Daniel Mrak Breakdown of academic impact, for papers by Vincenzo Nasillo Breakdown of academic impact, for papers by Seçkin Çağırgan
Rankless by CCL
2026